Search results
Results from the WOW.Com Content Network
The DPT vaccine or DTP vaccine is a class of combination vaccines to protect against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus (lockjaw). [7] The vaccine components include diphtheria and tetanus toxoids , and either killed whole cells of the bacterium that causes pertussis or pertussis antigens .
The wide age gap between six weeks and six years allows for children who fall behind in their vaccinations to still have the opportunity to be vaccinated. [16] From the moment of birth, babies can become infected with these life-threatening diseases, which is why this vaccine is recommended to be given so early on. [9]
Vaccine combinations (few exceptions), antibiotics, low-dose steroids (less than 20 mg per day), minor infections with low fever (below 38.5º Celsius), diarrhea, malnutrition, kidney or liver disease, heart or lung disease, non-progressive encephalopathy, well controlled epilepsy or advanced age, are not contraindications to vaccination.
DTP-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and whole-cell pertussis and hepatitis B (recombinant) vaccine (adsorbed) or DTP-Hep B. It protects against the infectious diseases diphtheria , tetanus , pertussis , and hepatitis B .
1982: Two doses of MMR vaccination at 14–18 months and 6 years of age were introduced in the national childhood vaccination programme. 2009: Rotavirus vaccine introduced at 2, 3 and 5 months to all children (September 2009) 2010: PCV introduced at 3, 5 and 12 months of age to all children (September 2010). 2013: HPV vaccination of girls ...
Lowering the recommended age for the vaccine will expand eligibility to people under 65 with health conditions that make them more likely to develop severe disease from the bacteria. Data from ...
Pertussis vaccine is a vaccine that protects against whooping cough (pertussis). [1] [2] There are two main types: whole-cell vaccines and acellular vaccines.[1] [2] The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Pfizer's vaccine was 91% effective at preventing symptomatic COVID-19, according to a trial of more than 2,200 kids aged 5-11. See the chart that convinced CDC advisors Pfizer's lower-dose vaccine ...